4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001209191-19-042874
President and CEO acquired 18,793 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chang David D President and CEO | 2019-07-18 | Other acquisition | +9,402 | 1,144,900 | I: show line 1 in the form | ||
| Chang David D President and CEO | 2019-07-18 | Other acquisition | +9,391 | 2,186,078 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…